Biden's Weight - QuikReader

Biden proposes weight loss drug coverage requirements for Medicare and Medicaid

Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration proposal.

Biden proposes Medicare and Medicaid cover weight-loss drugs for obese Americans

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday ...

Health - ABC News - 18 hours ago

Biden proposes huge expansion of US weight-loss drug coverage

State-backed insurance programmes would fund drugs for obese patients without separate health conditions

World - Financial Times - Yesterday

Biden proposes Medicare and Medicaid cover weight-loss drugs for 7.4m people

Move aims to tackle US’s chronic obesity problem, but poses a challenge to Trump’s incoming administration. The Biden administration is proposing to make “miracle” weight loss drugs free for ...

World - The Guardian - 22 hours ago

Biden proposes expanded coverage for weight loss drugs under Medicare, Medicaid

The Biden administration has proposed a plan for Medicare and Medicaid to offer coverage for weight loss medications, such as Ozempic and Wegovy.

Politics - NBC News - 20 hours ago

Biden proposes weight loss drug coverage by Medicare, Medicaid

President Biden's proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump's ...

Why Biden is proposing weight loss drug Medicare, Medicaid coverage

President Biden's proposal to expand Medicaid and Medicare coverage for some weight loss drugs could impact thousands of Americans. CBS News' Alexander Tin breaks down what's known about the ...

Biden seeks Medicare and Medicaid coverage of popular but costly weight-loss drugs for millions of Americans

Health - ABC News - Yesterday

Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would ...

Business - MarketWatch - Yesterday

Doctor says Biden's weight-loss drug proposal is a "formal recognition" that obesity is an illness

The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses ...

Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars

The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.

Business - MarketWatch - 2 hours ago

What to know about the Biden administration proposal to expand access to weight loss drugs

The Biden administration wants to expand access to popular weight loss drugs like Wegovy and Ozempic. The new proposal would allow millions of obese Americans covered by Medicaid and Medicare to be ...

Nurse’s death linked to approved weight-loss drug

Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

US group revises down upper end of full-year revenue estimates

Business - Financial Times - October 30

Hoping for a weight-loss pill? It could get closer to reality next week.

Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.

Business - MarketWatch - November 2

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

Meta makes its MobileLLM open for researchers, posting full weights

Developers and researchers interested in testing MobileLLM can now access the models on Hugging Face, fully integrated with the Transformers library.

Tech - VentureBeat - October 31

Counterfeit weight loss drugs sold online as demand for cheaper options grows

A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...

Counterfeit weight loss drugs feed demand for cheaper options

Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...

Soft as skin, strong as steel: Powerful magnetic muscles lift 1000x their weight

World - Yahoo News - November 11

Mother-of-two dies during Turkey weight-loss op

Janet Savage paid £2,750 for the procedure but stopped breathing during surgery.

Not just for weight loss: Wegovy may help curb alcohol addiction

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

Surging diabetes rate underscores vast opportunity in weight-loss drugs

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.

Business - MarketWatch - November 14

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy ...

Business - MarketWatch - November 16

Employers Get Pressure to Pay for Drugs Like Wegovy

Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.

Business - The Wall Street Journal - November 19

Novo Nordisk Launches Wegovy Weight-Loss Drug in China

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.